Ads
related to: how to treat proximal neuropathyhelperwizard.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
alternativebee.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Proximal diabetic neuropathy, also known as diabetic amyotrophy, is a complication of diabetes mellitus that affects the nerves that supply the thighs, hips, buttocks and/or lower legs. Proximal diabetic neuropathy is a type of diabetic neuropathy characterized by muscle wasting, weakness, pain, or changes in sensation/numbness of the leg.
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).
Nerve compression syndrome, or compression neuropathy, or nerve entrapment syndrome, is a medical condition caused by chronic, direct pressure on a peripheral nerve. [1] It is known colloquially as a trapped nerve , though this may also refer to nerve root compression (by a herniated disc , for example).
Diabetic neuropathy encompasses a series of different neuropathic syndromes which can be categorized as follows: [14] Focal and multifocal neuropathies: Mononeuropathy which affects one nerve; Amyotrophy or radiculopathy such as proximal diabetic neuropathy, affecting a specific pattern of nerves
According to Lopate, et al., methylprednisolone is a viable treatment for chronic inflammatory demyelinative polyneuropathy (which can also be treated with intravenous immunoglobulin). The authors also indicate that prednisone has greater adverse effects in such treatment, as opposed to intermittent (high-doses) of the aforementioned medication.
The characteristics are typical of demyelinating neuropathy with antimyelin-associated glycoprotein (MAG) antibodies; however, anti-MAG neuropathy is not included in the CIDP criteria according to the EFNS/PNS criteria, primarily due to the presence of a particular antibody and a different response to treatment.
Ads
related to: how to treat proximal neuropathyhelperwizard.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
alternativebee.com has been visited by 10K+ users in the past month